🩺 Bloating

## Overview Bloating is a subjective sensation of abdominal fullness, tightness, or pressure that is among the most common gastrointestinal (GI) complaints worldwide. Classified under ICD-10 code **R14.0** (abdominal distension/bloating), it may or may not be accompanied by objectively measurable increases in abdominal girth (visible distension). Population-based surveys suggest that **15–30 %** of adults in Western countries experience bloating at least occasionally, with approximately 6–10 % reporting it as a frequent or bothersome symptom [1][3]. Women report bloating roughly twice as often as men, and the symptom becomes an especially common search query around mealtimes, holidays, and during menstrual cycles. Bloating is a hallmark feature of several functional gastrointestinal disorders — particularly irritable bowel syndrome (IBS), where up to **90 %** of patients endorse it as one of their most troublesome symptoms [2]. However, bloating also accompanies a wide range of organic conditions, from celiac disease to ovarian pathology, which is why careful evaluation matters. This article reviews the evidence-based causes, red flags, self-care strategies, pharmacological options, and escalation thresholds for bloating. It is intended for general adult readers and does **not** replace individualized medical advice. --- ## Common Causes Bloating arises through several overlapping mechanisms. The causes below are ranked roughly by frequency in primary-care settings. ### 1. Functional Bloating and IBS (Most Common) Functional bloating, as defined by the Rome IV criteria, occurs when bloating is the predominant symptom in the absence of other functional bowel disorders. IBS—subdivided into IBS-C (constipation-predominant), IBS-D (diarrhea-predominant), and IBS-M (mixed)—is the single most common diagnosis in patients who present with chronic bloating. Pathophysiology involves **visceral hypersensitivity**, altered gut motility, gut–brain axis dysregulation, mild mucosal inflammation, and altered fermentation patterns in the colon [1][2]. ### 2. Dietary Factors — FODMAPs and Gas-Producing Foods Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are poorly absorbed short-chain carbohydrates that undergo colonic bacterial fermentation, producing hydrogen, methane, and carbon dioxide. Common high-FODMAP foods include onions, garlic, wheat, legumes, certain fruits, and sugar alcohols (sorbitol, mannitol). A landmark Monash University trial demonstrated that a low-FODMAP diet reduced bloating in approximately **70 %** of IBS patients [4]. ### 3. Aerophagia (Excessive Air Swallowing) Habitual air swallowing—often linked to fast eating, chewing gum, carbonated beverages, mouth breathing, or anxiety—increases intraluminal gas volume. This is generally more common in individuals with anxiety disorders or ill-fitting dentures. ### 4. Constipation Delayed colonic transit prolongs fermentation time and increases gas production. Stool retention also mechanically distends the colon and rectum, contributing to a sensation of fullness. Constipation-predominant IBS and chronic idiopathic constipation are major drivers of bloating. ### 5. Small Intestinal Bacterial Overgrowth (SIBO) Abnormal proliferation of bacteria in the small intestine leads to premature fermentation of ingested carbohydrates with excessive gas production. SIBO may complicate conditions such as diabetes mellitus, post-surgical states, scleroderma, and chronic proton-pump inhibitor (PPI) use [5]. ### 6. Carbohydrate Malabsorption (Lactose, Fructose) Lactase deficiency affects an estimated 65–70 % of the global population. Undigested lactose reaches the colon and is fermented by bacteria, producing gas and osmotically drawing water into the lumen. Fructose malabsorption follows a similar mechanism. ### 7. Celiac Disease Autoimmune enteropathy triggered by gluten ingestion causes villous atrophy and malabsorption. Bloating is a presenting symptom in up to **80 %** of celiac patients, and screening is recommended in anyone with chronic unexplained bloating [6]. ### 8. Gastroparesis Delayed gastric emptying—most often secondary to diabetes mellitus or idiopathic in origin—produces early satiety, nausea, and upper-abdominal bloating. ### 9. Gynecological Causes Ovarian cysts, endometriosis, and premenstrual hormonal fluctuations (progesterone slows GI motility) commonly cause lower-abdominal bloating in women of reproductive age. Notably, **persistent bloating of recent onset** is an early symptom of ovarian cancer and warrants investigation. ### 10. Medications Drugs that slow GI motility (opioids, anticholinergics, calcium channel blockers), promote gas (acarbose, lactulose), or alter the microbiome (antibiotics) are frequent iatrogenic contributors. --- ## RED FLAGS Seek **immediate medical attention** (emergency department or call emergency services) if bloating is accompanied by any of the following: - **Severe, sudden-onset abdominal pain** — may indicate perforation, volvulus, or ischemic bowel - **Inability to pass gas or stool combined with vomiting** — suggests bowel obstruction - **Bloody stool (melena or hematochezia)** — concerning for GI bleeding - **High fever (≥ 38.5 °C / 101.3 °F) with abdominal rigidity** — possible peritonitis - **Rapid, progressive abdominal distension with shortness of breath** — may indicate massive ascites, bowel obstruction, or intra-abdominal catastrophe - **Hemodynamic instability** (dizziness, rapid pulse, low blood pressure) with abdominal symptoms — suggests hemorrhage or sepsis - **Unintentional weight loss > 5 % body weight in 3–6 months** — red flag for malignancy - **New-onset bloating in a woman over age 50** with pelvic fullness or early satiety — ovarian cancer screening recommended per ACOG guidance - **Jaundice** (yellowing of skin/eyes) with bloating — suggests hepatobiliary or pancreatic pathology --- ## Self-Care at Home The following non-pharmacological measures have evidence supporting their benefit for uncomplicated bloating: ### Dietary Modification - **Low-FODMAP diet**: A structured 2–6-week elimination followed by systematic reintroduction is the best-studied dietary intervention. A 2016 systematic review found significant reductions in bloating scores compared to habitual diet [4]. Guidance from a registered dietitian is recommended. - **Smaller, more frequent meals**: Reduces gastric distension and post-prandial fermentation. - **Identify trigger foods**: Common culprits include beans, lentils, cruciferous vegetables (broccoli, cabbage), onions, carbonated drinks, and artificial sweeteners. - **Reduce carbonated beverages and chewing gum** to limit aerophagia. ### Physical Activity - Moderate exercise (e.g., 20–30 minutes of walking after meals) accelerates colonic transit and facilitates gas clearance. A randomized trial showed that mild physical activity significantly reduced bloating in IBS patients compared to sedentary controls [3]. ### Behavioral Approaches - **Abdominal massage**: Clockwise circular massage following the path of the colon may promote gas movement. - **Diaphragmatic breathing**: Reduces aerophagia and modulates visceral sensitivity via vagal tone. - **Cognitive-behavioral therapy (CBT) and gut-directed hypnotherapy**: Both have Level A evidence for IBS-related bloating per ACG guidelines [2]. Gut-directed hypnotherapy has shown durable symptom improvement at 12-month follow-up. ### Adequate Hydration and Fiber Titration - Gradually increasing dietary fiber (target 20–30 g/day) can improve constipation-related bloating, but rapid increases may paradoxically worsen gas. Soluble fiber (psyllium) is generally better tolerated than insoluble fiber (wheat bran) [2]. --- ## OTC Medications That Help The following over-the-counter options may provide relief. Consult a pharmacist or clinician if symptoms persist beyond 2–4 weeks. | Class | Example | Typical Adult Dose | Notes | |---|---|---|---| | **Simethicone** (anti-foaming agent) | Gas-X, Mylicon | 40–125 mg after meals and at bedtime (max 500 mg/day) | Breaks up gas bubbles in the GI tract; generally well tolerated; minimal systemic absorption. Evidence is modest — a meta-analysis showed small benefit over placebo [3]. | | **Alpha-galactosidase enzyme** | Beano | 2–3 tablets at the start of a meal containing fermentable carbohydrates | Breaks down oligosaccharides (raffinose, stachyose) before colonic fermentation. Not effective for lactose or fructose. Contraindicated in galactosemia. | | **Lactase enzyme** | Lactaid | 1–3 caplets with first bite of dairy | Hydrolyzes lactose; effective only for lactose-related bloating. Safe in pregnancy. | | **Psyllium husk** (soluble fiber) | Metamucil | 1 rounded tablespoon (≈ 5 g) in 240 mL water, 1–3×/day | Improves constipation-related bloating; titrate slowly. Adequate fluid intake essential to prevent obstruction. | | **Polyethylene glycol (PEG 3350)** | MiraLAX | 17 g in 240 mL water once daily | Osmotic laxative; effective for constipation-associated bloating. Generally well tolerated. Avoid in suspected bowel obstruction. | | **Peppermint oil capsules** (enteric-coated) | IBgard, Heather's Tummy Tamers | 180–225 mg, 1–2 capsules 30 min before meals, 2–3×/day | Antispasmodic (L-type calcium channel blockade in smooth muscle). A Cochrane review found significant benefit for IBS symptoms including bloating [7]. May cause heartburn if coating dissolves early; avoid in severe GERD. | | **Probiotics** | VSL#3, Align (Bifidobacterium infantis 35624) | Varies by product | *Bifidobacterium infantis 35624* showed significant reduction in bloating in a well-designed RCT [2]. Strain-specific effects; not all probiotics are equal. Generally safe, but use with caution in immunocompromised patients. | | **Activated charcoal** | CharcoCaps | 500–1000 mg before and after meals | May adsorb intestinal gas; limited evidence. Can interfere with absorption of medications — separate by at least 2 hours. | --- ## Prescription Options When bloating is refractory to dietary modification and OTC measures, prescription therapy may be warranted. These are typically prescribed by a gastroenterologist or primary-care physician. | Class | Example(s) | Indication | Notes | |---|---|---|---| | **Antispasmodics** | Hyoscine butylbromide (Buscopan), dicyclomine (Bentyl) | IBS-associated bloating and cramping | Anticholinergic side effects (dry mouth, urinary retention, blurred vision). Avoid in glaucoma, prostatic hypertrophy. | | **Prokinetics** | Prucalopride (Motegrity) | Chronic constipation with bloating | 5-HT₄ agonist; accelerates colonic transit. Generally well tolerated; headache most common side effect. | | **Secretagogues** | Linaclotide (Linzess), lubiprostone (Amitiza), plecanatide (Trulance) | IBS-C and chronic idiopathic constipation with bloating | Linaclotide (290 µg/day for IBS-C) significantly reduced bloating in phase III trials [2]. Diarrhea is the main side effect. Contraindicated in children < 6 years (linaclotide) and < 18 years (plecanatide). | | **Rifaximin** | Xifaxan | Non-constipated IBS bloating; SIBO | Non-absorbable antibiotic; FDA-approved for IBS-D. TARGET 3 trial showed significant improvement in bloating with 550 mg TID × 14 days, with durable response in ~35 % [5]. May be repeated. | | **Low-dose tricyclic antidepressants (TCAs)** | Amitriptyline 10–25 mg at bedtime | Visceral hypersensitivity-driven bloating | Modulate gut–brain axis; anticholinergic effects may worsen constipation. Requires gradual titration. | | **SSRIs** | Citalopram, fluoxetine (low dose) | Bloating with comorbid anxiety/depression | May help via central desensitization; GI side effects (nausea, diarrhea) possible. | | **Eluxadoline** | Viberzi | IBS-D with bloating | Mixed opioid-receptor agonist/antagonist. Contraindicated in patients without a gallbladder (risk of sphincter of Oddi spasm), pancreatitis history, or heavy alcohol use. | --- ## Lab Tests Typically Ordered When bloating is chronic (> 4 weeks), recurrent, or accompanied by alarm features, clinicians may order the following investigations: | Test | Rationale | |---|---| | **Complete blood count (CBC)** | Screen for anemia (iron deficiency may suggest celiac disease, GI blood loss, or malignancy). See [CBC](/tests/complete-blood-count). | | **C-reactive protein (CRP) / Erythrocyte sedimentation rate (ESR)** | Distinguish functional from inflammatory causes (elevated in IBD, infection). See [CRP](/tests/c-reactive-protein). | | **Tissue transglutaminase IgA (tTG-IgA)** with total serum IgA | Screen for celiac disease — recommended in all patients with chronic unexplained bloating [6]. See [Celiac panel](/tests/celiac-disease-panel). | | **Thyroid function tests (TSH, free T4)** | Hypothyroidism slows GI motility and may present with bloating and constipation. See [TSH](/tests/thyroid-stimulating-hormone). | | **Comprehensive metabolic panel (CMP)** | Assess liver function (rule out ascites-related distension), kidney function, glucose (diabetes → gastroparesis). | | **Hydrogen/methane breath test** | Diagnose lactose malabsorption, fructose malabsorption, or SIBO. Elevated methane specifically correlates with constipation-predominant symptoms. See [Breath test](/tests/hydrogen-breath-test). | | **Stool calprotectin** | Non-invasive marker for intestinal inflammation; helps differentiate IBS from IBD. See [Calprotectin](/tests/fecal-calprotectin). | | **CA-125 and transvaginal ultrasound** | Considered in women with new-onset persistent bloating (especially age > 50) to screen for ovarian pathology per ACOG guidance. | | **Abdominal X-ray / CT abdomen** | If obstruction, ileus, or significant distension is suspected. | | **Upper endoscopy and/or colonoscopy** | Indicated when alarm features are present (weight loss, anemia, family history of GI malignancy, age > 45–50 with new symptoms). | --- ## Special Populations ### Children and Adolescents Bloating is common in children and is most often functional (functional abdominal pain disorders per Rome IV pediatric criteria). Dietary triggers similar to adults apply. **Simethicone** drops (20 mg, 4×/day) may be used in infants for colic-associated gas, though evidence is limited. Lactose intolerance should be considered in older children. A low-FODMAP diet can be trialed under dietitian supervision. **Linaclotide and plecanatide are contraindicated in children under 6 and under 18, respectively** (FDA black-box warning for linaclotide in children < 2 due to fatal dehydration in animal studies). Always consult a pediatrician before administering any OTC medication to children; dosing should be weight-based and per product labeling or physician guidance. ### Pregnancy Bloating is extremely common during pregnancy due to elevated progesterone (relaxes smooth muscle, slowing GI motility) and mechanical compression by the growing uterus. Management is primarily dietary and lifestyle-based: - Small, frequent meals; avoid gas-producing foods - Gentle walking after meals - **Simethicone**: Generally considered safe in pregnancy (minimal systemic absorption; not assigned a specific FDA risk category under the new labeling system, but historically Category C — consult OB provider) - **Psyllium**: Safe and often recommended for pregnancy-related constipation - **PEG 3350**: Generally considered safe; poorly absorbed - **Avoid**: Castor oil (may stimulate uterine contractions), bismuth subsalicylate, activated charcoal (limited data) - Prescription antispasmodics and secretagogues should generally be avoided unless benefits clearly outweigh risks — discuss with obstetrician ### Elderly Bloating in older adults warrants a lower threshold for investigation, as the pretest probability of organic disease (diverticular disease, colorectal malignancy, medication-related causes, mesenteric ischemia) increases with age. Polypharmacy review is essential — opioids, calcium supplements, iron supplements, and anticholinergic medications are frequent contributors. PEG 3350 is generally well tolerated in the elderly. Use anticholinergic antispasmodics with caution due to risk of confusion, urinary retention, and falls. Prucalopride has been studied in elderly populations and appears safe. ### Athletes Exercise-related bloating is common, particularly in endurance athletes (runners, cyclists). Contributing factors include: - **Ischemic gut** during high-intensity exercise (blood diverted to skeletal muscle) - **Mechanical bouncing** of abdominal contents during running - **High-carbohydrate loading** before events (especially gels/drinks with fructose or sugar alcohols) - **Dehydration** slowing gastric emptying Management includes practicing race-day nutrition during training, avoiding high-FODMAP foods in the 24 hours before competition, maintaining hydration, and using simethicone prophylactically if needed. Enteric-coated peppermint oil capsules taken 30–60 minutes before exercise may reduce symptoms. --- ## When to Escalate Use the following thresholds as a guide: ### Same-Day GP / Primary-Care Appointment - Bloating persisting daily for **> 3 weeks** without clear dietary explanation - Associated change in bowel habits (new constipation or diarrhea) - Moderate abdominal pain that interferes with daily activities - Bloating with significant fatigue or suspected anemia ### Urgent Care (Within 24–48 Hours) - Bloating with **vomiting** and inability to keep fluids down - Bloating with **fever** (≥ 38 °C / 100.4 °F) and localized abdominal tenderness - Significant visible distension that has developed over days - Bloating with **painful urination or vaginal bleeding** (possible gynecologic emergency) ### Emergency Department / Call Emergency Services - Severe, acute-onset bloating with **peritoneal signs** (rigidity, rebound tenderness, guarding) - **Complete inability to pass gas or stool** for > 12–24 hours with vomiting (bowel obstruction) - Bloating with **hematemesis** (vomiting blood) or **large-volume rectal bleeding** - Signs of **shock**: rapid heart rate, low blood pressure, lightheadedness, cold/clammy skin - Bloating with **chest pain or severe shortness of breath** (large-volume ascites or diaphragmatic compromise) > **General rule**: If you are unsure whether your symptoms warrant emergency care, err on the side of caution and seek evaluation. Bloating is usually benign, but its overlap with serious conditions means that red-flag symptoms should never be ignored. --- ## References [1] Lacy BE, Gabbard SL, Crowell MD. Pathophysiology, Evaluation, and Treatment of Bloating: Hope, Hype, or Hot Air? *Gastroenterology & Hepatology*. 2011;7(11):729-739. PMID:22298969. [2] Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. *American Journal of Gastroenterology*. 2021;116(1):17-44. PMID:33315591. [3] Seo AY, Kim N, Oh DH. Abdominal Bloating: Pathophysiology and Treatment. *Journal of Neurogastroenterology and Motility*. 2013;19(4):433-453. PMID:24199004. [4] Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. *Gastroenterology*. 2014;146(1):67-75.e5. PMID:24076059. [5] Pimentel M, Lembo A, Chey WD, et al. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation (TARGET 3). *New England Journal of Medicine*. 2011;364(1):22-32. PMID:21208106. [6] National Institute for Health and Care Excellence (NICE). Coeliac disease: recognition, assessment and management. NICE guideline [NG20]. September 2015 (updated December 2015). Available at: https://www.nice.org.uk/guidance/ng20. [7] Khanna R, MacDonald JK, Levesque BG. Peppermint Oil for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. *Journal of Clinical Gastroenterology*. 2014;48(6):505-512. PMID:24100754. [8] American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 716: The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk. *Obstetrics & Gynecology*. 2017;130(3):e146-e149. --- *This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment tailored to your individual circumstances. Content last reviewed April 2026.*